Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system
| Published in: | Haematologica |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2016-10-01
|
| Online Access: | https://haematologica.org/article/view/7864 |
| _version_ | 1850366778165690368 |
|---|---|
| author | Thomas Prebet Pierre Fenaux Norbert Vey |
| author_facet | Thomas Prebet Pierre Fenaux Norbert Vey |
| author_sort | Thomas Prebet |
| collection | DOAJ |
| container_title | Haematologica |
| format | Article |
| id | doaj-art-e52ee3e773464e78a8bfc09df6bb440f |
| institution | Directory of Open Access Journals |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2016-10-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| spelling | doaj-art-e52ee3e773464e78a8bfc09df6bb440f2025-08-19T23:03:05ZengFerrata Storti FoundationHaematologica0390-60781592-87212016-10-011011010.3324/haematol.2016.150714Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring systemThomas Prebet0Pierre Fenaux1Norbert Vey2Smilow Cancer center at Yale New Haven Hospital, CT, USA;Groupe Francophone des myélodysplasies, Hopital Saint Louis, Paris, FranceGroupe Francophone des myélodysplasies, Hopital Saint Louis, Paris, France;Service Hematologie Senior, Hopital Saint Louis, Paris, FranceGroupe Francophone des myélodysplasies, Hopital Saint Louis, Paris, France;Service Hematologie 2, Institut Paoli-Calmettes, Marseille, Francehttps://haematologica.org/article/view/7864 |
| spellingShingle | Thomas Prebet Pierre Fenaux Norbert Vey Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system |
| title | Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system |
| title_full | Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system |
| title_fullStr | Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system |
| title_full_unstemmed | Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system |
| title_short | Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system |
| title_sort | predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine validation of the north american mds consortium scoring system |
| url | https://haematologica.org/article/view/7864 |
| work_keys_str_mv | AT thomasprebet predictingoutcomeofpatientswithmyelodysplasticsyndromesafterfailureofazacitidinevalidationofthenorthamericanmdsconsortiumscoringsystem AT pierrefenaux predictingoutcomeofpatientswithmyelodysplasticsyndromesafterfailureofazacitidinevalidationofthenorthamericanmdsconsortiumscoringsystem AT norbertvey predictingoutcomeofpatientswithmyelodysplasticsyndromesafterfailureofazacitidinevalidationofthenorthamericanmdsconsortiumscoringsystem |